Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GYRE

Gyre Therapeutics (GYRE)

Gyre Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GYRE
DateTimeSourceHeadlineSymbolCompany
31/05/202406:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GYREGyre Therapeutics Inc
31/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
31/05/202406:05GlobeNewswire Inc.Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial HypertensionNASDAQ:GYREGyre Therapeutics Inc
31/05/202406:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GYREGyre Therapeutics Inc
29/05/202406:05GlobeNewswire Inc.Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® IndexesNASDAQ:GYREGyre Therapeutics Inc
14/05/202406:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GYREGyre Therapeutics Inc
10/05/202406:10GlobeNewswire Inc.Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GYREGyre Therapeutics Inc
10/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
08/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
26/03/202421:00GlobeNewswire Inc.Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GYREGyre Therapeutics Inc
21/03/202422:00GlobeNewswire Inc.Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. NussbaumNASDAQ:GYREGyre Therapeutics Inc
16/12/202301:04PR Newswire (US)Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B FundingNASDAQ:GYREGyre Therapeutics Inc
13/11/202323:00GlobeNewswire Inc.Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver MeetingNASDAQ:GYREGyre Therapeutics Inc
03/11/202308:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GYREGyre Therapeutics Inc
02/11/202308:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GYREGyre Therapeutics Inc
02/11/202307:58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GYREGyre Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GYRE